BRAF and malignant colon neoplasm: In addition, we demonstrate that reactivation of ERK is due to incomplete degradation of mutant BRAF by AUY922, whereas reactivation of Akt is triggered by the activity of CDC37 in mutant BRAF colon cancer cells.